PT  - JOURNAL ARTICLE
AU  - Cerqueira-Silva, Thiago
AU  - Oliveira, Juliane F.
AU  - de Araújo Oliveira, Vinicius
AU  - Veras Florentino, Pilar Tavares
AU  - Sironi, Alberto
AU  - Penna, Gerson O.
AU  - Pereira Ramos, Pablo Ivan
AU  - Boaventura, Viviane Sampaio
AU  - Barral-Netto, Manoel
AU  - Marcilio, Izabel
TI  - Early warning system using primary healthcare data in the post-COVID-19-pandemic era: Brazil nationwide case-study
AID  - 10.1101/2023.11.24.23299005
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.11.24.23299005
4099  - http://medrxiv.org/content/early/2023/11/27/2023.11.24.23299005.short
4100  - http://medrxiv.org/content/early/2023/11/27/2023.11.24.23299005.full
AB  - Background Syndromic surveillance utilising primary health care (PHC) data is a valuable tool for early outbreak detection, as demonstrated in the potential to identify COVID-19 outbreaks. However, the potential of such an early warning system in the post-COVID-19 era remains largely unexplored.Methods We analysed PHC encounter counts due to respiratory complaints registered in the Brazilian database of the Universal Health System between January and July 2023. We applied EARS (variation C1-C2-C3) and EVI to estimate the weekly thresholds. An alarm was determined when the number of encounters exceeded the week-specific threshold. We used data on hospitalisation due to respiratory disease to classify weeks in which the number of cases surpassed predetermined thresholds as anomalies. We compared EARS and EVI’s efficacy in anticipating anomalies.Findings A total of 119 anomalies were identified across 116 immediate regions during the study period. The EARS-C2 presented the highest early alarm rate, with 81/119 (68%) early alarms, and C1 the lowest, with 71 (60%) early alarms. The lowest true positivity was the EARS-C1 118/1354 (8.7%) and the highest EARS-C3 99/856 (11.6%).Conclusion Routinely collected PHC data can be successfully used to detect respiratory disease outbreaks in Brazil. Syndromic surveillance enhances timeliness in surveillance strategies, albeit with lower specificity. A combined approach with other strategies is essential to strengthen accuracy, offering a proactive and effective public health response against future outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is part of the Alert-Early System of Outbreaks with Pandemic Potential (ĂSOP) program funded by Fundação Oswaldo Cruz and the Rockefeller Foundation. Additional support was provided by the Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB, Grant number PNX0008/2014).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study is based on secondary, aggregated, non-identified data, and was approved by the Ethical Review Board of Oswaldo Cruz Foundation - Brasília Regional Office, CAAE 61444122.0.0000.0040.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesOur agreement with the MoH for accessing the databases patently denies authorization of access to a third party. Any information for assessing the databases must be addressed to the Brazilian MoH at https://datasus.saude.gov.br/, and requests can be addressed to datasus{at}saude.gov.br